Hospital & Healthcare Management November 20, 2021
Kai Vogt

In the health care industry, changes are occurring at a rapid pace. People, machines, and information are becoming even more interconnected. Meanwhile, unanticipated events such as the Covid-19 pandemic affect the pharma and biotech industry as well. To meet the needs of our customers, innovations at the interface between pharmaceutical products, services, and digital data must be accelerated. As a globally leading contract development and manufacturing organization (CDMO), Vetter is continuously engaged in this swiftness of change. This is achieved through the testing of future technology and the implementation of new digital systems as necessary. Given all the variabilities occurring within the industry, there is only one constant at Vetter: to sustainably improve the patients’ quality of life through...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Digital Health, Patient / Consumer, Pharma, Pharma / Biotech, Technology
Brazil’s plan for low-cost CAR-Ts
PacBio’s Repeat Expansion Panel, Owkin-Sanofi AI Take on Immunology, More
STAT+: Borrowing an idea from cancer immunotherapy, scientists make old-mice immune systems youthful again
Moderna gets Blackstone backing for flu vaccine R&D
FDA Approves Winrevair, Merck’s Novel Treatment for Pulmonary Arterial Hypertension

Share This Article